Law360, New York (April 17, 2015, 4:19 PM EDT) -- Eli Lily Pharmaceutal Co. persuaded a Texas federal court Thursday to throw out a proposed class action by a woman claiming its antidepressant Cymbalta caused withdrawal symptoms that she said the drugmaker did not sufficiently warn about.
U.S. District Judge Lee H. Rosenthal granted Eli Lilly's motion to dismiss, agreeing with the drugmaker that plaintiff Marilyn Pickaree exceeded the two-year statute of limitations for personal injury actions under Texas law. Pickaree, who alleged she suffered significant withdrawal effects in the days after she stopped taking Cymbalta in April 2008, had filed her suit in December 2014.
Judge Rosenthal ruled that Pickaree...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!